Apoptosis

SJR Rank #1,153H-index: 138SJR: 2.242Best quartile: Q1APC: US$5,090
Journal website: aims, scope and author guidelines
Publisher

Springer

Country

United States

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • Biochemistry (medical)Q1
  • Cancer ResearchQ1
  • Cell BiologyQ1
  • Clinical BiochemistryQ1
  • Pharmaceutical ScienceQ1
  • PharmacologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Cell death mechanisms and regulationAutophagy in Disease and TherapyCancer-related Molecular PathwaysMitochondrial Function and PathologyRNA Interference and Gene DeliveryPhagocytosis and Immune RegulationFerroptosis and cancer prognosisEndoplasmic Reticulum Stress and DiseaseNF-κB Signaling Pathwaysinterferon and immune responses

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs080160240320

Documents per Year

2022202504590135180

Detailed Information

ISSN

1360-8185, 1573-675X

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

10.00

References per Document

94.56

Coverage

1996-2026

Scope

Apoptosis is an international peer-reviewed journal, published monthly. The Journal is devoted to the rapid publication of innovative basic and clinically-oriented investigations into programmed cell death. It aims to stimulate both research on the basis of mechanisms of apoptosis and on its role in various human disease processes including: cancer, autoimmune disease, viral infection, AIDS, cardiovascular disease, neurodegenerative disorders, osteoporosis and ageing. The Editor-In-Chief recognises the need to encourage the development of clinical therapies against apoptosis-related diseases. Original Articles, Reviews, Short Communications, Letters to the Editor and Book Reviews will be considered for publication in Apoptosis.

Metrics from SCImago Journal Rank 2025. View on SCImago